{"id":59803,"date":"2024-02-28T06:16:55","date_gmt":"2024-02-28T06:16:55","guid":{"rendered":"https:\/\/medsname.com\/olanzap\/"},"modified":"2026-04-30T10:23:54","modified_gmt":"2026-04-30T10:23:54","slug":"olanzap","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/olanzap\/","title":{"rendered":"Olanzap"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8d6;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p style=\"margin-bottom:0;\">Olanzap (Olanzapine 2,5 \/ 5 \/ 7,5 \/ 10 \/ 15 \/ 20 mg) je atypick\u00e9 antipsychotikum pro l\u00e9\u010dbu schizofrenie, bipol\u00e1rn\u00ed m\u00e1nie a udr\u017eovac\u00ed terapii, l\u00e9\u010debn\u011b rezistentn\u00ed deprese (v kombinaci s fluoxetinem) a akutn\u00ed agitace. Nejsiln\u011bj\u0161\u00ed antipsychotick\u00fd \u00fa\u010dinek mezi atypick\u00fdmi antipsychotiky \u2014 ale tak\u00e9 nejvy\u0161\u0161\u00ed metabolick\u00e1 z\u00e1t\u011b\u017e.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Olanzap na MedsBase je dod\u00e1v\u00e1n p\u0159\u00edmo od v\u00fdrobce certifikovan\u00e9ho WHO-GMP v jednoduch\u00e9m, diskr\u00e9tn\u00edm balen\u00ed. Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 20pracovn\u00edchdenn\u00ed lh\u016fta pro doru\u010den\u00ed, nebo v\u00e1m z\u00e1silku zdarma p\u0159epo\u0161leme \u2014 a oprav\u0148uje v\u00e1s k \u00fa\u010dasti v na\u0161em <a href=\"https:\/\/medsbase.com\/cs\/loyalty-points\/\">v\u011brnostn\u00edm programu<\/a>. Dod\u00e1v\u00e1me do v\u011bt\u0161iny zem\u00ed po cel\u00e9m sv\u011bt\u011b.<\/p>\n<h2>Co je Olanzap a jak funguje<\/h2>\n<p>Olanzap je tableta olanzapinu dod\u00e1van\u00e1 spole\u010dnost\u00ed Sun Pharma. Dostupn\u00e9 s\u00edly: <strong>2,5 \/ 5 \/ 7,5 \/ 10 \/ 15 \/ 20 mg<\/strong>. Olanzapin je thienobenzodiazepinov\u00fd atypick\u00fd antipsychotikum se silnou D2 antagonizac\u00ed, silnou 5-HT2A antagonizac\u00ed a v\u00fdraznou blok\u00e1dou H1 (sedace, p\u0159\u00edr\u016fstek hmotnosti), M1 (anticholinergn\u00ed \u00fa\u010dinky) a \u03b11 (ortostatick\u00e1 hypotenze). Profil receptor\u016f H1+M1 je zodpov\u011bdn\u00fd jak za jeho uklid\u0148uj\u00edc\u00ed\/sedativn\u00ed \u00fa\u010dinek (u\u017eite\u010dn\u00fd p\u0159i akutn\u00ed agitaci), tak za jeho metabolickou z\u00e1t\u011b\u017e.<\/p>\n<h2>Indikace a d\u00e1vkov\u00e1n\u00ed<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indikace<\/th>\n<th>Po\u010d\u00e1te\u010dn\u00ed d\u00e1vka<\/th>\n<th>C\u00edlov\u00e1 d\u00e1vka<\/th>\n<th>Maxim\u00e1ln\u00ed d\u00e1vka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Schizofrenie (dosp\u011bl\u00ed)<\/td>\n<td>5\u201310 mg 1\u00d7 denn\u011b<\/td>\n<td>10\u201320 mg 1\u00d7 denn\u011b<\/td>\n<td>20 mg<\/td>\n<\/tr>\n<tr>\n<td>Schizofrenie (dosp\u00edvaj\u00edc\u00ed \u2265 13 let)<\/td>\n<td>2,5\u20135 mg 1\u00d7 denn\u011b<\/td>\n<td>10 mg 1\u00d7 denn\u011b<\/td>\n<td>20 mg<\/td>\n<\/tr>\n<tr>\n<td>Bipol\u00e1rn\u00ed m\u00e1nie (dosp\u011bl\u00ed)<\/td>\n<td>10\u201315 mg 1\u00d7 denn\u011b<\/td>\n<td>10\u201320 mg 1\u00d7 denn\u011b<\/td>\n<td>20 mg<\/td>\n<\/tr>\n<tr>\n<td>Akutn\u00ed agitace (i.m.)<\/td>\n<td>10 mg i.m.<\/td>\n<td>\u2014<\/td>\n<td>3 d\u00e1vky\/24h<\/td>\n<\/tr>\n<tr>\n<td>L\u00e9\u010dba rezistentn\u00ed deprese (s fluoxetinem)<\/td>\n<td>5 mg + 20 mg fluoxetinu<\/td>\n<td>5\u201318 mg<\/td>\n<td>18 mg<\/td>\n<\/tr>\n<tr>\n<td>Star\u0161\u00ed dosp\u011bl\u00ed<\/td>\n<td>2,5\u20135 mg 1\u00d7 denn\u011b<\/td>\n<td>5\u201310 mg 1\u00d7 denn\u011b<\/td>\n<td>dle sn\u00e1\u0161enlivosti<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>D\u016fle\u017eit\u00e9 bezpe\u010dnostn\u00ed aspekty<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>FDA black-box \u2014 psych\u00f3za spojen\u00e1 s demenc\u00ed<\/strong><\/p>\n<p style=\"margin-bottom:0;\">V\u0161echna atypick\u00e1 antipsychotika nesou varov\u00e1n\u00ed FDA black-box pro zv\u00fd\u0161enou mortalitu (p\u0159edev\u0161\u00edm kardiovaskul\u00e1rn\u00ed a infek\u010dn\u00ed) p\u0159i pou\u017eit\u00ed k l\u00e9\u010db\u011b behavior\u00e1ln\u00edch poruch u star\u0161\u00edch dosp\u011bl\u00fdch s demenc\u00ed. <strong>Atypick\u00e1 antipsychotika nejsou schv\u00e1lena pro psych\u00f3zu nebo agitovanost spojenou s demenc\u00ed<\/strong>. Pou\u017eit\u00ed u t\u00e9to populace je off-label, posledn\u00ed mo\u017enost\u00ed, \u010dasov\u011b omezen\u00e9 a vy\u017eaduje explicitn\u00ed rozhovor o rizic\u00edch a p\u0159\u00ednosech.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Nejv\u011bt\u0161\u00ed metabolick\u00e1 z\u00e1t\u011b\u017e mezi atypick\u00fdmi antipsychotiky<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Olanzapin zp\u016fsobuje nejv\u011bt\u0161\u00ed p\u0159\u00edr\u016fstek hmotnosti (obvykle 4\u201310 kg v prvn\u00edch 6 m\u011bs\u00edc\u00edch, n\u011bkdy v\u00fdrazn\u011b v\u00edce), nejv\u011bt\u0161\u00ed inzulinovou rezistenci a nejv\u011bt\u0161\u00ed poruchy lipid\u016f ze v\u0161ech b\u011b\u017en\u011b pou\u017e\u00edvan\u00fdch antipsychotik. U pacient\u016f se m\u016f\u017ee b\u011bhem m\u011bs\u00edc\u016f od zah\u00e1jen\u00ed l\u00e9\u010dby rozvinout diabetes 2. typu. <strong>Povinn\u00e9 monitorov\u00e1n\u00ed: hmotnost p\u0159i ka\u017ed\u00e9 n\u00e1v\u0161t\u011bv\u011b; glyk\u00e9mie nala\u010dno\/HbA1c a lipidy nala\u010dno na za\u010d\u00e1tku, po 12 t\u00fddnech a pot\u00e9 ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f.<\/strong> Od za\u010d\u00e1tku l\u00e9\u010dby pacienty pou\u010dte o diet\u011b a cvi\u010den\u00ed.<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Sedace a anticholinergn\u00ed z\u00e1t\u011b\u017e<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Siln\u00e1 sedace v prvn\u00edch 1\u20132 t\u00fddnech. Anticholinergn\u00ed \u00fa\u010dinky (sucho v \u00fastech, z\u00e1cpa, obt\u00ed\u017en\u00e9 mo\u010den\u00ed) jsou b\u011b\u017en\u00e9. Ob\u011b skupiny \u00fa\u010dink\u016f se zm\u00edr\u0148uj\u00ed, ale nezmiz\u00ed \u00fapln\u011b.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Olanzapin i.m. + benzodiazepin \u2013 opatrn\u011b<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Kombinace i.m. olanzapinu s parenter\u00e1ln\u00edmi benzodiazepiny vedla k p\u0159\u00edpad\u016fm t\u011b\u017ek\u00e9 hypotenze, respira\u010dn\u00ed deprese a \u00famrt\u00ed. Pokud jsou oba l\u00e9ky klinicky nutn\u00e9 p\u0159i akutn\u00ed agitaci, pod\u00e1vejte je s odstupem \u2265 1 hodiny a pacienta pe\u010dliv\u011b monitorujte.<\/p>\n<\/div>\n<h2>\u010cast\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/h2>\n<ul>\n<li><strong>P\u0159\u00edr\u016fstek hmotnosti a metabolick\u00fd syndrom<\/strong> \u2014 dominantn\u00ed dlouhodob\u00e1 obava.<\/li>\n<li><strong>Sedace<\/strong> \u2014 univerz\u00e1ln\u00ed p\u0159i zah\u00e1jen\u00ed l\u00e9\u010dby.<\/li>\n<li><strong>Ortostatick\u00e1 hypotenze<\/strong> \u2014 b\u011b\u017en\u00e9 p\u0159i zah\u00e1jen\u00ed l\u00e9\u010dby; u star\u0161\u00edch dosp\u011bl\u00fdch titrujte pomalu.<\/li>\n<li><strong>Anticholinergn\u00ed<\/strong> \u2014 sucho v \u00fastech, z\u00e1cpa, obt\u00ed\u017en\u00e9 mo\u010den\u00ed.<\/li>\n<li><strong>Akathisie, EPS<\/strong> \u2014 m\u00e9n\u011b \u010dast\u00e9 ne\u017e u risperidonu, \u010dast\u011bj\u0161\u00ed ne\u017e u aripiprazolu.<\/li>\n<li><strong>Prolaktin<\/strong> \u2014 m\u00edrn\u00fd vzestup; men\u0161\u00ed ne\u017e u risperidonu.<\/li>\n<li><strong>Jatern\u00ed<\/strong> \u2014 p\u0159echodn\u00e9 zv\u00fd\u0161en\u00ed AST\/ALT je b\u011b\u017en\u00e9.<\/li>\n<\/ul>\n<h2>Interakce l\u00e9k\u016f<\/h2>\n<ul>\n<li><strong>Inhibitory CYP1A2<\/strong> (fluvoxamin, ciprofloxacin) \u2014 v\u00fdrazn\u011b zvy\u0161uj\u00ed hladiny olanzapinu.<\/li>\n<li><strong>Kou\u0159en\u00ed<\/strong> \u2014 indukuje CYP1A2; ku\u0159\u00e1ci maj\u00ed ni\u017e\u0161\u00ed hladiny a pot\u0159ebuj\u00ed vy\u0161\u0161\u00ed d\u00e1vky; ukon\u010den\u00ed kou\u0159en\u00ed m\u016f\u017ee zp\u016fsobit toxicitu.<\/li>\n<li><strong>Karbamazepin<\/strong> \u2014 siln\u00e1 indukce CYP1A2; zvy\u0161uje clearance olanzapinu.<\/li>\n<li><strong>CNS depresiva<\/strong> \u2014 aditivn\u00ed sedace.<\/li>\n<li><strong>Anticholinergika<\/strong> \u2014 aditivn\u00ed z\u00e1t\u011b\u017e.<\/li>\n<\/ul>\n<h2>T\u011bhotenstv\u00ed, kojen\u00ed, pediatrie<\/h2>\n<p>T\u011bhotenstv\u00ed: omezen\u00e1 data; zva\u017ete proti nel\u00e9\u010den\u00e9mu onemocn\u011bn\u00ed; expozice v pozdn\u00edm t\u011bhotenstv\u00ed m\u016f\u017ee zp\u016fsobit neonat\u00e1ln\u00ed EPS nebo abstinen\u010dn\u00ed p\u0159\u00edznaky. Kojen\u00ed: p\u0159ech\u00e1z\u00ed do ml\u00e9ka; obvykle vy\u017eaduje alternativu nebo pe\u010dliv\u00e9 sledov\u00e1n\u00ed. D\u011bti: schv\u00e1leno od 13 let (schizofrenie, bipol\u00e1rn\u00ed porucha).<\/p>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i 15\u201330 \u00b0C v p\u016fvodn\u00edm obalu.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Pro\u010d Olanzap zp\u016fsobuje tak v\u00fdrazn\u00fd p\u0159\u00edr\u016fstek hmotnosti?<\/h3>\n<p>Kombinovan\u00fd \u00fa\u010dinek olanzapinu na H1 antihistaminikum, antagonismus 5-HT2C a dal\u0161\u00ed receptory zp\u016fsobuje silnou stimulaci chuti k j\u00eddlu, zpomalen\u00e9 nasycen\u00ed a zm\u011bnu preference sacharid\u016f. N\u00e1r\u016fst hmotnosti je z\u00e1visl\u00fd na d\u00e1vce, ale vyskytuje se i p\u0159i n\u00edzk\u00fdch d\u00e1vk\u00e1ch. Poradenstv\u00ed ohledn\u011b stravy a cvi\u010den\u00ed od 1. t\u00fddne plus pravideln\u00e9 sledov\u00e1n\u00ed hmotnosti je povinn\u00e9.<\/p>\n<h3>Jak se Olanzap li\u0161\u00ed od risperidonu nebo aripiprazolu?<\/h3>\n<p>Olanzapin m\u00e1 nejsiln\u011bj\u0161\u00ed akutn\u00ed antipsychotick\u00fd \u00fa\u010dinek a nejrychlej\u0161\u00ed zklid\u0148uj\u00edc\u00ed \u00fa\u010dinek \u2014 u\u017eite\u010dn\u00e9 p\u0159i akutn\u00ed agitaci. Nev\u00fdhodou je nejv\u011bt\u0161\u00ed metabolick\u00e1 z\u00e1t\u011b\u017e. Risperidon je \u00fa\u010dinn\u011bj\u0161\u00ed u n\u011bkter\u00fdch pozitivn\u00edch p\u0159\u00edznak\u016f, ale v\u00fdrazn\u011b zvy\u0161uje prolaktin. Aripiprazol je metabolicky nej\u010dist\u0161\u00ed, ale zp\u016fsobuje v\u00edce akatizie.<\/p>\n<h3>M\u011bl bych sledovat hladinu cukru v krvi p\u0159i u\u017e\u00edv\u00e1n\u00ed Olanzapu?<\/h3>\n<p>Ano \u2014 nala\u010dno glyk\u00e9mie nebo HbA1c na za\u010d\u00e1tku, po 12 t\u00fddnech a pot\u00e9 ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f. Olanzapin m\u016f\u017ee zp\u016fsobit diabetes ji\u017e b\u011bhem n\u011bkolika m\u011bs\u00edc\u016f od za\u010d\u00e1tku u\u017e\u00edv\u00e1n\u00ed, n\u011bkdy se projev\u00ed diabetickou ketoacid\u00f3zou. Nevynech\u00e1vejte sledov\u00e1n\u00ed.<\/p>\n<h3>M\u016f\u017ee se Olanzap u\u017e\u00edvat dlouhodob\u011b?<\/h3>\n<p>Ano \u2014 zejm\u00e9na pro udr\u017eovac\u00ed l\u00e9\u010dbu schizofrenie, kde olanzapin \u010dasto p\u0159ekon\u00e1v\u00e1 jin\u00e1 atypick\u00e1 antipsychotika v m\u00ed\u0159e relapsu. Metabolick\u00e1 z\u00e1t\u011b\u017e je hlavn\u00edm d\u016fvodem, pro\u010d dlouhodob\u00e9 u\u017e\u00edv\u00e1n\u00ed vy\u017eaduje pe\u010dliv\u00e9 sledov\u00e1n\u00ed hmotnosti, gluk\u00f3zy a lipid\u016f, plus aktivn\u00ed management kardiometabolick\u00e9ho rizika.<\/p>\n<h3>Za jak dlouho Olanzap za\u010dne \u00fa\u010dinkovat?<\/h3>\n<p>Zklid\u0148uj\u00edc\u00ed \u00fa\u010dinek do 1\u20132 hodin po prvn\u00ed peror\u00e1ln\u00ed d\u00e1vce. Antipsychotick\u00fd \u00fa\u010dinek se rozv\u00edj\u00ed b\u011bhem 1\u20132 t\u00fddn\u016f; pln\u00fd antipsychotick\u00fd a stabilizuj\u00edc\u00ed n\u00e1ladu \u00fa\u010dinek nast\u00e1v\u00e1 za 4\u20136 t\u00fddn\u016f.<\/p>\n<h3>Jak je to s \u0159\u00edzen\u00edm p\u0159i u\u017e\u00edv\u00e1n\u00ed Olanzapu?<\/h3>\n<p>Vyhn\u011bte se \u0159\u00edzen\u00ed v prvn\u00edch 1\u20132 t\u00fddnech titrace. V\u011bt\u0161ina pacient\u016f na stabiln\u00ed d\u00e1vce \u0159\u00edd\u00ed norm\u00e1ln\u011b, ale sedace m\u016f\u017ee p\u0159etrv\u00e1vat u vy\u0161\u0161\u00edch d\u00e1vek.<\/p>\n<h3>Je orodispergovateln\u00e1 forma odli\u0161n\u00e1?<\/h3>\n<p>Ano \u2014 existuj\u00ed orodispergovateln\u00e9 (ODT) verze olanzapinu (Zyprexa Zydis, Olimelt), kter\u00e9 se rozpou\u0161t\u011bj\u00ed na jazyku bez vody. Jsou bioekvivalentn\u00ed standardn\u00edm tablet\u00e1m, ale u\u017eite\u010dn\u00e9 u pacient\u016f s nejistou adherenc\u00ed nebo dysfagi\u00ed.<\/p>\n<h3>M\u016f\u017ee se Olanzap kombinovat s fluoxetinem?<\/h3>\n<p>Ano \u2014 kombinace olanzapinu s fluoxetinem (OFC, Symbyax) je schv\u00e1lena FDA pro l\u00e9\u010dbu rezistentn\u00ed deprese a bipol\u00e1rn\u00ed deprese. Fluoxetin \u010d\u00e1ste\u010dn\u011b kompenzuje nedostatek antidepresivn\u00edho \u00fa\u010dinku olanzapinu; olanzapin p\u0159id\u00e1v\u00e1 silnou stabilizuj\u00edc\u00ed slo\u017eku n\u00e1lady.<\/p>\n<h3>Pro\u010d je d\u016fle\u017eit\u00e9 kou\u0159en\u00ed?<\/h3>\n<p>Kou\u0159en\u00ed siln\u011b indukuje CYP1A2, co\u017e je hlavn\u00ed metabolick\u00fd enzym olanzapinu. Ku\u0159\u00e1ci metabolizuj\u00ed olanzapin rychleji a pot\u0159ebuj\u00ed vy\u0161\u0161\u00ed d\u00e1vky; n\u00e1hl\u00e9 p\u0159eru\u0161en\u00ed kou\u0159en\u00ed (nap\u0159. p\u0159i hospitalizaci) m\u016f\u017ee zp\u016fsobit toxicitu olanzapinu, pokud nen\u00ed upravena d\u00e1vka. Informujte p\u0159edepisuj\u00edc\u00edho l\u00e9ka\u0159e o zm\u011bn\u011b ku\u0159\u00e1ck\u00e9ho statusu.<\/p>\n<h3>M\u016f\u017ee se Olanzap n\u00e1hle vysadit?<\/h3>\n<p>Obecn\u011b ne \u2014 vysazujte postupn\u011b b\u011bhem 2\u20134 t\u00fddn\u016f. N\u00e1hl\u00e9 vysazen\u00ed m\u016f\u017ee zp\u016fsobit cholinergn\u00ed rebound (nevolnost, pocen\u00ed, nespavost) a relaps psych\u00f3zy. Nikdy nevysazujte bez souhlasu l\u00e9ka\u0159e.<\/p>\n<h2>Dal\u0161\u00ed l\u00e9ky na du\u0161evn\u00ed zdrav\u00ed<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aripicon\/\">Aripicon (Aripiprazol \u2014 parci\u00e1ln\u00ed agonista D2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/olanzap\/\">Olanzap (Olanzapin \u2014 \u00fa\u010dinn\u00e9 antipsychotikum)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/risdone\/\">Risdone (Risperidon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/seroquit\/\">Seroquit (Quetiapin \u2014 bipol\u00e1rn\u00ed deprese)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/atlura\/\">Atlura (Lurasidon \u2014 metabolicky neutr\u00e1ln\u00ed)<\/a><\/li>\n<\/ul>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;font-size:0.9em;\">\n<strong>Zdravotn\u00ed prohl\u00e1\u0161en\u00ed.<\/strong> Tato str\u00e1nka m\u00e1 vzd\u011bl\u00e1vac\u00ed charakter a nenahrazuje individu\u00e1ln\u00ed l\u00e9ka\u0159skou radu. Farmakoterapie du\u0161evn\u00edho zdrav\u00ed by m\u011bla b\u00fdt zah\u00e1jena, monitorov\u00e1na a upravov\u00e1na pod dohledem kvalifikovan\u00e9ho l\u00e9ka\u0159e. Pokud vy nebo n\u011bkdo, koho zn\u00e1te, pro\u017e\u00edv\u00e1 sebevra\u017eednou krizi, okam\u017eit\u011b kontaktujte m\u00edstn\u00ed z\u00e1chrann\u00e9 slu\u017eby nebo volejte linku prevence sebevra\u017ed ve va\u0161\u00ed zemi (USA\/Kanada: 988; UK: Samaritans 116 123; mezin\u00e1rodn\u00ed seznam: <a href=\"https:\/\/findahelpline.com\/\" rel=\"nofollow noopener\" target=\"_blank\">findahelpline.com<\/a>).\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Olanzap (Olanzapin 2,5\u201320 mg) \u2014 thienobenzodiazepinov\u00fd atypick\u00fd antipsychotikum pro schizofrenii, bipol\u00e1rn\u00ed m\u00e1nii a l\u00e9\u010debn\u011b rezistentn\u00ed MDD. Nejsiln\u011bj\u0161\u00ed akutn\u00ed antipsychotikum \u2014 nejvy\u0161\u0161\u00ed metabolick\u00e1 z\u00e1t\u011b\u017e.<\/p>","protected":false},"featured_media":59804,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3906],"product_tag":[4748,4527],"class_list":{"0":"post-59803","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_tag-olanzap","10":"product_tag-olanzapine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/59803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=59803"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/59804"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=59803"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=59803"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=59803"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=59803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}